Enzymatica AB (publ) (STO:ENZY)

Enzymatica AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	13.15	33.13	75.21	8.37	50.69	31.62
Cash & Short-Term Investments	13.15	33.13	75.21	8.37	50.69	31.62
Cash Growth	-70.97%	-55.95%	799.02%	-83.49%	60.31%	31.65%
Accounts Receivable	4.35	10	12.09	11.34	14.23	16.32
Other Receivables	4.48	2.15	3.31	3.13	3.48	3.75
Receivables	8.83	12.15	15.4	14.47	17.71	20.07
Inventory	14.47	18.92	16.71	11.5	11.51	12.44
Prepaid Expenses	-	0.83	4.68	4.45	4.94	0.65
Total Current Assets	36.44	65.03	112	38.78	84.85	64.78
Property, Plant & Equipment	22.94	10.37	14.4	16.48	16.4	15.16
Goodwill	-	63.21	63.21	63.21	63.21	63.21
Other Intangible Assets	63.18	0.33	0.66	1.12	1.62	1.99
Long-Term Deferred Tax Assets	2.06	2.41	2.64	2.32	2.32	2.12
Long-Term Deferred Charges	-	0.65	2.33	4	6.02	9.79
Other Long-Term Assets	0	-	-	-	-	-
Total Assets	124.63	141.98	195.22	125.91	174.41	157.04

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.9	8.75	9.81	7.37	6.67	7.61
Accrued Expenses	-	5.86	5.07	9.51	17.08	19.24
Current Portion of Long-Term Debt	-	-	-	-	-	0.27
Current Portion of Leases	2.65	1.02	1.18	1.22	1.2	1.24
Other Current Liabilities	10.35	2.17	1.77	14.34	2.06	2.58
Total Current Liabilities	14.9	17.8	17.83	32.44	27	30.94
Long-Term Debt	-	-	-	14.85	20.88	-
Long-Term Leases	11.52	0.01	1.02	2.01	0.25	1.12
Other Long-Term Liabilities	0	-0	-	-	-	0
Total Liabilities	26.42	17.81	18.86	49.3	48.12	32.07

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	98.22	9.71	9.71	6.57	6.57	5.97
Additional Paid-In Capital	-	656.29	655.9	507.2	507.2	438.83
Retained Earnings	-	-542.44	-490.55	-437.37	-387.64	-318.99
Comprehensive Income & Other	-	0.62	1.31	0.21	0.17	-0.85
Total Common Equity	98.22	124.17	176.37	76.61	126.29	124.97
Shareholders' Equity	98.22	124.17	176.37	76.61	126.29	124.97
Total Liabilities & Equity	124.63	141.98	195.22	125.91	174.41	157.04

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	14.17	1.02	2.2	18.08	22.32	2.63
Net Cash (Debt)	-1.02	32.11	73.01	-9.71	28.37	28.99
Net Cash Growth	-	-56.02%	-	-	-2.11%	216.26%
Net Cash Per Share	-0.00	0.13	0.38	-0.06	0.18	0.20
Filing Date Shares Outstanding	242.74	242.74	242.74	164.26	164.26	149.32
Total Common Shares Outstanding	242.74	242.74	242.74	164.26	164.26	149.32
Working Capital	21.54	47.23	94.16	6.34	57.85	33.84
Book Value Per Share	0.40	0.51	0.73	0.47	0.77	0.84
Tangible Book Value	35.03	60.64	112.5	12.28	61.46	59.78
Tangible Book Value Per Share	0.14	0.25	0.46	0.07	0.37	0.40
Machinery	-	24.76	26.59	24.37	23.53	18.74

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error